Test detail

## Ivermectin and COVID-19: Organizing the Disconnect Between Media and Science This is a problem where science, media, and politics are complexly intertwined, so let me organize it from multiple angles. --- ## Why Mainstream Media is Negative ### 1. Major RCT Results ``` ・TOGETHER trial (Brazil, n=1500+) → No significant difference ・ACTIV-6 trial (US) → No significant difference ・PRINCIPLE trial (UK) → No significant difference Most large, rigorous RCTs show negative results ``` ### 2. Meta-Analysis Quality Issues - **Elgazzar paper** (large meta-analysis) → **Retracted for data fraud** - **Ivermectin for COVID-19 meta-analysis** → Effect disappears when retracted papers are excluded - "Garbage in, garbage out" problem ### 3. Regulatory Authority Judgments - FDA, EMA, WHO do not recommend it - Media tends to follow authority institutions --- ## Main Arguments in Meta-Analyses Showing Efficacy | Research Group | Claim | Caveat | |---|---|---| | Bryant et al. | 62% mortality reduction | Includes low-quality studies | | Hill et al. | Improvement trend | Author later added caveats | | ivmmeta.com | Consistent efficacy | Not an independent institution | --- ## Factors Making the Problem More Complex ### Scientific Uncertainty - **Regional variation**: High parasitic infection rates could be confounding factors in some regions - **Timing**: May differ between early intervention and post-severe phase treatment - **Dosage**: Non-uniform protocols across trials ### Structural Issues ``` Patent expired → No R&D incentive for pharmaceutical companies → Large-scale trials difficult to fund → Evidence gaps naturally emerge ``` ### Media and Political Factors - Motivation to avoid contradicting vaccine promotion policies - Labeling as "the drug Trump supporters promote" (especially in US) - Trust erosion due to exaggeration and conspiracy theories on social media --- ## Current Fair Assessment **Strong arguments from the negative position:** - Strictly designed large-scale RCTs show negative results - Retracted papers have contaminated "efficacy" meta-analyses **Arguments from the skeptical (cautious toward negation) position:** - Not all RCTs are homogeneous (target population, severity, timing) - Publication bias can work in both directions - Cochrane Review (2022) also contains caveats: "insufficient certainty" **Cochrane Review 2022 Conclusion:** > "Current evidence neither definitively supports nor refutes ivermectin use" --- ## Conclusive Summary | Question | Answer | |---|---| | Has complete ineffectiveness been proven? | **No** | | Has effectiveness been proven? | **No (currently)** | | Is media negation 100% scientifically sound? | **No (political and structural factors are mixed in)** | | Should it be dismissed as conspiracy theory? | **No** | --- ## Personally Important Perspective **Blind trust in mainstream media is as dangerous as blind trust in counter-mainstream sources.** This problem serves as an important case study showing how "science can be contaminated by politics, economics, and media," and serves as training material for developing critical evaluation skills of evidence quality. Are there specific papers or trials you'd like to know more about?

Regarding ivermectin's efficacy against COVID-19, while meta-analyses and individual studies show varying results, mainstream media's negative stance has several explanations. 1. **Research Quality and Consistency**: Many ivermectin studies have small sample sizes or methodological flaws. Because higher-quality research is considered more trustworthy, mainstream media prioritizes large-scale, rigorous studies. 2. **Major Public Health Authority Recommendations**: The WHO, FDA, EMA and other major public health institutions do not currently recommend ivermectin for COVID-19. Since these institutions typically base guidelines on rigorous evidence, media follows this tendency. 3. **Data Interpretation and Bias**: Meta-analyses combine multiple studies but can mislead if bias or heterogeneity isn't considered. Not all studies are equally weighted, and meta-analysis quality greatly affects results. 4. **Political and Social Factors**: Ivermectin discussions sometimes involve political/social influences. When certain groups spread information lacking scientific basis, media responds with cautious reporting in opposition. 5. **Availability of More Effective Treatments**: Since vaccines and proven treatments exist, ivermectin receives relatively less attention. These factors lead mainstream media to handle ivermectin cautiously, generally presenting negative views.

COVID-19 ivermectin efficacy reports and meta-analysis opinions largely stem from **research quality, evolution of evidence, and the scientific consensus-formation process.** ### 1. Meta-Analysis Views on Efficacy You are correct that **early-stage or certain condition-specific meta-analyses** do suggest the possibility of ivermectin showing some efficacy against COVID-19. * **Early meta-analyses:** * Many primarily included relatively small-scale studies, observational research, or preprints. * Some studies suggested infection prevention, shortened recovery periods, or reduced severe illness/death risk. * **Problems and Challenges:** * Many early studies had **methodological flaws (high bias risk), small sample sizes, inconsistent results, or data reliability concerns**. * Several studies had suspected data fabrication and were later retracted. ### 2. Why Mainstream Media Shows Negative Views Mainstream media's negative reporting on ivermectin is based on **"current highest-quality scientific evidence and major health authority recommendations."** 1. **Large-Scale Randomized Controlled Trial (RCT) Results:** * Over time, numerous **large, rigorously designed RCTs** enrolling hundreds to thousands (e.g., TOGETHER, ACTIV-6 trials) were conducted. * Most high-quality RCTs concluded ivermectin showed **no statistically significant effects** on prevention, hospitalization risk, mortality, or symptom persistence. * RCTs are far more trustworthy than observational or pilot studies in the evidence hierarchy. 2. **Latest Meta-Analyses and Systematic Reviews:** * **Updated meta-analyses and systematic reviews** incorporating these large RCT results show no clear COVID-19 efficacy for ivermectin. * Independent bodies like the **Cochrane Library** conclude insufficient evidence supports its use. 3. **Major Health Authority Recommendations:** * The WHO, FDA, EMA, NIH, and other **leading global health institutions do not recommend ivermectin** for COVID-19 treatment or prevention. * These institutions evaluate the best available scientific evidence and base recommendations on results. 4. **Information Credibility and Public Safety:** * Mainstream media has responsibility to provide reliable information and prevent harm from misinformation. * When scientific consensus clearly shows "no effect," recommending unapproved drugs risks wasting medical resources and losing opportunities for truly effective treatments. * Cases of health damage from self-administered veterinary ivermectin have been reported. ### Summary Mainstream media negativity reflects that **current highest-quality evidence (especially large RCTs) and major health institution guidelines do not support COVID-19 ivermectin efficacy.** Early positive meta-analyses were based on limited data; subsequent rigorous studies overturned those findings. Science evolves—if stronger evidence emerges, views change—but current conclusion is "insufficient clear evidence of efficacy."